Cannabix Technologies to Present Multi-Drug Breath Technology at BC Centre for Excellence on Substance Use Disorders

VANCOUVER, British Columbia, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana, multi-drug, and alcohol breath testing technologies, is pleased to announce that its Chief Scientific Officer, Dr. Raj Attariwala, will be presenting the Company's emerging multi-drug breath testing technology at the BC Centre for Excellence conference on substance use disorder being held in Vancouver, British Columbia on November 13.